OncLive Enriches Strategic Alliance Program with Four New Partners to Enhance Cancer Research, Treatment and Education Content

Article

OncLive, a leading digital provider of resources and information to oncology professionals, has enhanced its Strategic Alliance Program and growing collection of content providers with the addition of four new partners.

PLAINSBORO, N.J. (May 17, 2016)OncLive®, a leading digital provider of resources and information to oncology professionals, has enhanced its Strategic Alliance Program and growing collection of content providers with the addition of four new partners:

The Angeles Clinic & Research Institute — Los Angeles, California

Known for excellence in cancer treatment, research and education, The Angeles Clinic & Research Institute has established an international reputation for developing new cancer therapies, providing the best in experimental and traditional treatments, and expertly guiding and training the next generation of clinicians. Committed to bringing innovative therapeutic options to all patients with cancer, the organization’s board-certified, fellowship-trained medical oncologists, surgeons, immunotherapists, pathologists and dermatologists work closely together to advance cancer care.

Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine — New York, New York

With a mission to ensure that patients have access to emerging new therapies in a supportive and caring environment, while training future researchers and leaders in clinical care, the Sandra and Edward Meyer Cancer Center is a collaborative, multidisciplinary research enterprise located at Weill Cornell Medicine, one of the country’s top-ranked clinical and medical research centers, in affiliation with New York-Presbyterian, the best hospital in New York according to U.S. News & World Report. The Meyer Cancer Center engages more than 250 scientists, pathologists, bioinformaticians, surgeons, oncologists, radiologists and other clinicians, who collaborate with colleagues at Cornell University’s Ithaca campus and other institutions, to take fundamental discoveries from bench to bedside and back again.

Georgia Regents University (GRU) Cancer Center — Augusta, Georgia

The GRU Cancer Center is a multi-disciplinary academic cancer center whose mission is to reduce the burden of cancer in Georgia, and across the globe, through superior care, innovation and education. Focused on both research and clinical treatment, its patient-centered approach includes first-in-the-nation treatment protocols, an experimental therapeutics program that includes specialized clinics for phase I clinical trials and immunotherapy, and a variety of ancillary programs — including nutritional and genetic counseling – designed with holistic healing in mind. Overall, the GRU Cancer Center’s vision is to be a global leader in cancer clinical care, discovery innovation, translational research and professional education and public awareness.

Sanford Burnham Prebys Medical Discovery Institute - La Jolla, California, and Orlando, Florida

Recognized for its world-class National Cancer Institute-designated Cancer Center and the Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute (SBP) is an independent, nonprofit research organization that blends cutting-edge fundamental research with robust drug discovery to address unmet clinical needs in the areas of cancer, neuroscience, immunity and metabolic disorders. Dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow, SBP takes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. SBP is also known for its world-class capabilities in stem cell research and drug discovery technologies.

“OncLive’s editorial and marketing teams will publicize and promote public awareness of these organizations’ latest advances in cancer research, treatment and education,” said Michael Hennessy Jr., president of Michael J. Hennessy Associates Inc., which produces OncLive. “There will also be an extensive amount of new content directly from the partners for oncology professionals to access on OncLive.”

The four new partners join OncLive’s Strategic Alliance Program as the latest of nearly 70 partners, including other leading cancer centers, nursing schools and oncology network providers around the country.

About OncLive

A digital platform of resources for practicing oncologists, OncLive.com  offers oncology professionals information they can utilize to help provide the best patient care. OncLive is the official website for Michael J. Hennessy Associates Inc.’s Oncology Specialty Group, which publishes OncologyLive, Oncology Nursing News, Oncology Business Management and more.  Michael J. Hennessy Associates Inc. is a full-service health care communications company offering education, research, medical media, curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE reaches patients, cancer centers and advocacy groups.

# # #

Media Contact:

Michael J. LaCosta

Executive Director of Public Relations

mjlacosta@mjhassoc.com

551-655-3718

Related Videos
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Video 1 - "HR+/HER2- Early-Stage Breast Cancer: Background and Risk Stratification "